Status: Not yet recruiting
The Purpose of This Study is to Evaluate the Efficacy and Safety of W2505.
The purpose of this study is to evaluate the efficacy and safety of W2505.
Participants needed: 228
Trial details
Phase: Phase 3Age: 19+Biological sex: MaleType: InterventionalSponsor: GL Pharm Tech CorporationUpdated: Oct 5, 2026Locations: 1
Eligibility criteria
Male aged 19 years or older. [+3]
Primary hypoactive sexual desire. [+2]